Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Remifentanil and Remimazolam to Limit Patient Movement
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-09-04
- Lead Sponsor
- Egymedicalpedia
- Target Recruit Count
- 70
- Registration Number
- NCT06583811
- Locations
- 🇪🇬
Al-Azhar University hospitals, Cairo, Egypt
Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation
- Conditions
- Interventions
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Nordsjaellands Hospital
- Target Recruit Count
- 2684
- Registration Number
- NCT06564857
Efficacy of Remifentanil in Preventing Emergence Agitation
- Conditions
- Interventions
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Target Recruit Count
- 99
- Registration Number
- NCT06539013
- Locations
- 🇹🇷
Health Sciences University Gazi Yaşargil Training and Research Hospital, Diyarbakır, Kayapınar, Turkey
Efficacy and Safety Studies of Oliceridine Fumarate
- Conditions
- Interventions
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Chun Pan
- Target Recruit Count
- 292
- Registration Number
- NCT06454292
Efficacy and Safety of Oxycodone Hydrochloride for Long-term Analgesia in ICU Patients
- Conditions
- Interventions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06444997
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
Dexmedetomidine and Remifentanil in NORA
- Conditions
- Interventions
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Baskent University Ankara Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT06403670
- Locations
- 🇹🇷
Baskent University Ankara Hospital, Ankara, Cankaya, Turkey
SPI and Remifentanil in Skull Pin Fixation
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-26
- Target Recruit Count
- 27
- Registration Number
- NCT06331663
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Dexmedetomidine vs. Remifentanil Conscious Sedation for Stapedotomy/Stapedectomy
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 100
- Registration Number
- NCT06283836
- Locations
- 🇷🇴
Cluj County Clinical Emergency Hospital, Cluj Napoca, Cluj, Romania
Effect of Sufentanil on the Postoperative Pain
- Conditions
- Interventions
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06260046
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Korea, Republic of
Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Sichuan Provincial People's Hospital
- Target Recruit Count
- 93
- Registration Number
- NCT06205719
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.